Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors

Clinical trial NCT01184807 · COMPLETED

Trial details

NCT number: NCT01184807
Sponsor: Otsuka Beijing Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumour

Start date: 2009-12-01
Primary completion: 2013-06-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.